I’m doing ok on ocrelizumab ( 3rd year just done) and had a good innings with natalizumab before that. In the UK I’m not eligible for HSCT unless I relapse on ocrelizumab. That may change of course.

I’m not sure whether HSCT is right for me given that it has some pretty big downsides. My latent symptoms are well controlled at the moment and don’t affect my quality of life too much. If I had to manage a thyroid disorder as a result of HSCT I’m not sure that would be an improvement for me.